Arbutus Biopharma Corp Live Stock Price Today, Share Analysis and Chart

Name: Arbutus Biopharma Corp: Is Infosys Ltd. worth buying?
Item: Arbutus Biopharma Corp
Rating: 1.41066675
Author: Trendlyne DVM scores

about

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can b...

4.14 -0.06 (-1.43%)

53.33% Gain from 52W Low

1.3M

XNAS Volume

High vol.+loss this week

XNAS 21 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

6.2 / 100

Technically Neutral

50.3 / 100

1Yr Price target upside is 37%

3 analysts

Arbutus Biopharma Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Arbutus Biopharma Corp Live Stock Price Today, Share Analysis and Chart

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can b...

53.33% Gain from 52W Low

High vol.+loss this week

SWOT Analysis

Arbutus Biopharma Corp Live Price Chart